ETON Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 19:56):

Stats
Dzisiejszy wolumen	24 915.00
Średni wolumen	61 048.00
Kapitalizacja rynkowa	93.12M
EPS	$0 ( 2024-03-14 )
Następna data zysków	( $-0.0200 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-363.00
ATR14	$0.0340 (0.94%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Gruber James R.	Buy	144 677	Stock Option (Right to buy)
2024-02-13	Adams Jennifer Mckie	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Brynjelsen Sean	Buy	438 633	Stock Option (Right to buy)
2024-02-13	Casamento Charles J	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Krempa David	Buy	144 677	Stock Option (Right to buy)

INSIDER POWER
55.37
Last 96 transactions
Buy: 4 266 352 \| Sell: 3 981 653

Wolumen Korelacja

Długi: 0.10 (neutral)

Krótki: -0.39 (neutral)

Signal:(56.367) Neutral

Eton Pharmaceuticals Inc Korelacja

10 Najbardziej pozytywne korelacje
POWL	0.923
ALXN	0.914
HPLTU	0.909
LQDA	0.908
FTII	0.906
ARIZ	0.906
HERAU	0.904
BRIV	0.903
CFFE	0.903
FEXD	0.902

10 Najbardziej negatywne korelacje
IRBT	-0.909
SPCX	-0.909
SIDU	-0.9
LGMK	-0.9
ORPH	-0.891
CSSEP	-0.891
NCBS	-0.889
VFF	-0.887
NAKD	-0.886
PIII	-0.883

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eton Pharmaceuticals Inc Korelacja - Waluta/Towar

0.13
( neutral )

0.02
( neutral )

0.00
( neutral )

-0.07
( neutral )

-0.55
( weak negative )

-0.25
( neutral )

Eton Pharmaceuticals Inc Finanse

Annual	2022
Przychody:	$21.25M
Zysk brutto:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2022
Przychody:	$21.25M
Zysk brutto:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2021
Przychody:	$21.83M
Zysk brutto:	$19.21M (87.99 %)
EPS:	$-0.0800

FY	2020
Przychody:	$39 000.00
Zysk brutto:	$-247 000 (-633.33 %)
EPS:	$-1.330

Financial Reports:

No articles found.

Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.